UnitedHealth Group Incorporated $UNH Shares Sold by BCS Wealth Management

BCS Wealth Management trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 51.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,413 shares of the healthcare conglomerate’s stock after selling 1,499 shares during the quarter. BCS Wealth Management’s holdings in UnitedHealth Group were worth $382,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of the business. Cidel Asset Management Inc. boosted its stake in shares of UnitedHealth Group by 38.8% during the 1st quarter. Cidel Asset Management Inc. now owns 12,757 shares of the healthcare conglomerate’s stock valued at $3,452,000 after buying an additional 3,565 shares during the last quarter. Richards Merrill & Peterson Inc. raised its holdings in UnitedHealth Group by 5.3% in the first quarter. Richards Merrill & Peterson Inc. now owns 2,647 shares of the healthcare conglomerate’s stock valued at $716,000 after acquiring an additional 134 shares in the last quarter. New Covenant Trust Company N.A. grew its holdings in UnitedHealth Group by 8.5% during the 1st quarter. New Covenant Trust Company N.A. now owns 1,116 shares of the healthcare conglomerate’s stock worth $302,000 after acquiring an additional 87 shares in the last quarter. Amarillo National Bank increased its position in shares of UnitedHealth Group by 11.2% in the 1st quarter. Amarillo National Bank now owns 990 shares of the healthcare conglomerate’s stock worth $268,000 after purchasing an additional 100 shares during the last quarter. Finally, HHM Wealth Advisors LLC lifted its position in shares of UnitedHealth Group by 1.9% during the first quarter. HHM Wealth Advisors LLC now owns 3,377 shares of the healthcare conglomerate’s stock worth $914,000 after purchasing an additional 63 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Bank of America raised its price target on UnitedHealth Group to $475 from $450 and reiterated a buy rating, signaling additional upside from current levels. Benzinga article on price target increase
• Positive Sentiment: Multiple articles highlighted UnitedHealth Group as a top long-term value stock, which may be supporting sentiment among growth-at-a-reasonable-price investors. Zacks article on long-term value stock
• Positive Sentiment: Commentary from Jim Cramer recommending UNH as a buy added to the upbeat tone around the stock. Motley Fool article on Jim Cramer
• Positive Sentiment: UNH also reached a proposed FTC settlement over insulin rebating practices, which could reduce regulatory uncertainty if finalized. Yahoo Finance article on FTC settlement
• Neutral Sentiment: Several additional pieces described UnitedHealth as steady in healthcare or discussed whether it is a buy, but did not add a major new catalyst beyond the generally favorable sentiment. Kalkine Media article on steady performance

Analyst Ratings Changes

Several brokerages have issued reports on UNH. Mizuho upped their price objective on UnitedHealth Group from $440.00 to $460.00 and gave the company an “outperform” rating in a research note on Monday, June 8th. UBS Group boosted their price target on UnitedHealth Group from $410.00 to $460.00 and gave the company a “buy” rating in a report on Friday, May 22nd. Oppenheimer raised their price objective on UnitedHealth Group from $385.00 to $405.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 22nd. Wells Fargo & Company boosted their target price on shares of UnitedHealth Group from $370.00 to $397.00 and gave the company an “overweight” rating in a research note on Wednesday, April 22nd. Finally, Sanford C. Bernstein restated an “outperform” rating on shares of UnitedHealth Group in a research report on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $410.79.

UnitedHealth Group Stock Performance

Shares of UNH opened at $405.86 on Thursday. The firm has a fifty day moving average of $379.62 and a 200-day moving average of $331.17. The company has a market cap of $368.58 billion, a price-to-earnings ratio of 30.65, a price-to-earnings-growth ratio of 1.65 and a beta of 0.64. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.80 and a current ratio of 0.80. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $415.98.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, beating the consensus estimate of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The firm had revenue of $111.65 billion for the quarter, compared to the consensus estimate of $109.84 billion. During the same period last year, the firm posted $7.20 EPS. UnitedHealth Group’s quarterly revenue was up 2.0% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 18.32 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Investors of record on Monday, June 15th were given a $2.32 dividend. The ex-dividend date was Monday, June 15th. This represents a $9.28 annualized dividend and a yield of 2.3%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.21. UnitedHealth Group’s payout ratio is 70.09%.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of the business’s stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the transaction, the chief executive officer owned 17,805 shares in the company, valued at approximately $6,320,775. The trade was a 4.30% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.28% of the stock is owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.